ATE476965T1 - Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren - Google Patents

Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren

Info

Publication number
ATE476965T1
ATE476965T1 AT05759293T AT05759293T ATE476965T1 AT E476965 T1 ATE476965 T1 AT E476965T1 AT 05759293 T AT05759293 T AT 05759293T AT 05759293 T AT05759293 T AT 05759293T AT E476965 T1 ATE476965 T1 AT E476965T1
Authority
AT
Austria
Prior art keywords
amphotericin
sterol
multilamellar
enriched
production method
Prior art date
Application number
AT05759293T
Other languages
English (en)
Inventor
Jitendra Verma
Lily Verma
Krishan Tripathi
Original Assignee
Verma Jitendra Nath
Lily Verma
Tripathi Krishan Kumar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verma Jitendra Nath, Lily Verma, Tripathi Krishan Kumar filed Critical Verma Jitendra Nath
Application granted granted Critical
Publication of ATE476965T1 publication Critical patent/ATE476965T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT05759293T 2004-06-11 2005-06-13 Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren ATE476965T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1113DE2004 2004-06-11
PCT/IN2005/000193 WO2005120460A1 (en) 2004-06-11 2005-06-13 Sterol enriched mixed lammelarity amphotericin intercalating liposomes in saline and the process for their preparation

Publications (1)

Publication Number Publication Date
ATE476965T1 true ATE476965T1 (de) 2010-08-15

Family

ID=34972096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05759293T ATE476965T1 (de) 2004-06-11 2005-06-13 Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren

Country Status (9)

Country Link
US (1) US20070218119A1 (de)
EP (1) EP1771156B8 (de)
JP (1) JP4966855B2 (de)
CN (1) CN101014322A (de)
AT (1) ATE476965T1 (de)
AU (1) AU2005251572B2 (de)
BR (1) BRPI0511371A (de)
DE (1) DE602005022876D1 (de)
WO (1) WO2005120460A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2488160B1 (de) * 2009-10-16 2020-07-01 Lifecare Innovations Pvt. Ltd. Amphotericin-liposomenformulierung, umfassend cholesterin für die bekämpfung von pilzinfektionen
WO2017150705A1 (ja) * 2016-03-04 2017-09-08 栗田工業株式会社 選択性透過膜及びその製造方法、該選択性透過膜を用いる水処理方法
FI3694526T3 (fi) 2017-10-11 2025-02-06 Univ Illinois Genotyypistä riippumaton toimintakyvyn palautus pienimolekyylisillä bikarbonaattikanavilla kystistä fibroosia varten
IL315719A (en) 2022-03-21 2024-11-01 Univ Illinois Prosthetic assemblies of ion channels containing lipid-coated amphotericin B crystals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2134869A (en) * 1983-02-15 1984-08-22 Squibb & Sons Inc Method of preparing liposomes and products produced thereby
US4744989A (en) * 1984-02-08 1988-05-17 E. R. Squibb & Sons, Inc. Method of preparing liposomes and products produced thereby
US4766046A (en) * 1985-09-27 1988-08-23 Liposome Technology, Inc. Stabilized liposome/amphotericin composition and method

Also Published As

Publication number Publication date
DE602005022876D1 (de) 2010-09-23
WO2005120460A1 (en) 2005-12-22
EP1771156B8 (de) 2010-09-15
JP4966855B2 (ja) 2012-07-04
AU2005251572B2 (en) 2010-03-11
AU2005251572A1 (en) 2005-12-22
EP1771156B1 (de) 2010-08-11
BRPI0511371A (pt) 2008-03-11
US20070218119A1 (en) 2007-09-20
JP2008501782A (ja) 2008-01-24
EP1771156A1 (de) 2007-04-11
CN101014322A (zh) 2007-08-08

Similar Documents

Publication Publication Date Title
NO20075136L (no) Nye liposompreparater
CA2690111A1 (en) Anthelmintic combination
FR15C0009I2 (fr) Compositions de gel phospholipide destinees a l'administration medicamenteuse et des methodes de traitement utilisant celles-ci
EP1792927A4 (de) Neues blockcopolymer, micellenzubereitung und antikrebsmittel, das diese als wirkbestandteil enthält
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
AR049137A1 (es) Formulacion de irinotecan en vesicula cerrada, para el tratamiento del cancer
DE60118743D1 (de) Methode zur behandlung und prävention von ansteckenden krankheiten
DE602004013993D1 (de) R für biologische wirksubstanz zur oralen verabreichung
EA200702633A1 (ru) Вакцина против малярии
AR082803A1 (es) Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p
EP1596868A4 (de) Verfahren zur behandlung von schwerer herzinsuffizienz und medikament dafür
WO2022197899A3 (en) Treatment of pain in pediatric patients by administration of sustained-release liposomal anesthetic compositions
BRPI0418157A (pt) terapêutica de tumores alogênicos
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE476965T1 (de) Sterol-angereicherte multilamellare amphotericin- enthaltende liposomen in kochsalzlösung und herstellungsverfahren
ATE488226T1 (de) Mahonia aquifolium extrakt, extraktionsverfahren und diesen enthaltende pharmazeutische zusammensetzung
WO2004069224A3 (en) Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
DK1638492T3 (da) Præoperativ behandling af postoperativ smerte
van den Hurk et al. Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia
BRPI0417797A (pt) soro sangüìneo biologicamente ativo, métodos para produzi-lo e seus usos
MD3381F1 (en) Method of treating the chronic parotitis to children
ATE548038T1 (de) Behandlung von arzneiresistenten tumoren
EA200300787A1 (ru) Композиция для принятия ванн и способ ее применения
Frankel Various toxicities: 5 case reports
UA3370U (uk) Спосіб лікування центральної хоріоретинальної дистрофії

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties